Core Laboratories Inc. /DE/(CLB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,281 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CLB Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Core Laboratories Inc. /DE/ (CLB), a Energy sector company. 13F Pro's AI-powered ranking engine scores CLB at 36.1/100 on a 32-signal composite quality model, placing it at rank #2,281 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (19.0) and revenue growth (26.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 48.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Core Laboratories Inc. /DE/ reports quarterly revenue of $124.6M, net income of $6.0M, an operating margin of 7.3%. Top institutional holders of CLB by reported 13-F value include ARIEL INVESTMENTS, BlackRock, DISCIPLINED GROWTH INVESTORS, based on the most recent SEC filings. CLB trades on the NYSE exchange and files with the SEC under CIK 1958086. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CLB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Core Laboratories Inc. /DE/ directly from SEC EDGAR. Core Laboratories Inc. /DE/'s 13F Pro composite quality score has ranged between 36 and 56 since 2024, currently 36.1 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q2 2026
$124.6M
Net Income
Q2 2026
$6.0M
Free Cash Flow
Q2 2026
$3.1M
Operating Margin
Q2 2026
7.3%
ROIC
Q2 2026
9.4%
D/E Ratio
Q2 2026
0.43
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+0.5% YoYNet Income
-5.5% YoYOperating Income
-3.6% YoYEPS (Diluted)
-4.5% YoYTotal Assets
-1.1% YoYTotal Debt
-11.7% YoYOp. Cash Flow
-34.3% YoYFree Cash Flow
-42.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $526.5M +0.5% | $523.8M +2.8% | $509.8M +4.1% | $489.7M +4.1% | $470.3M | — |
| Net Income | $29.7M -5.5% | $31.4M -14.4% | $36.7M +88.5% | $19.5M -1.4% | $19.7M | — |
| Operating Income | $56.5M -3.6% | $58.6M +7.2% | $54.6M +31.6% | $41.5M -8.3% | $45.3M | — |
| EPS (Diluted) | $0.63 -4.5% | $0.66 -14.3% | $0.77 +83.3% | $0.42 +0.0% | $0.42 | — |
| Total Assets | $584.0M -1.1% | $590.4M +0.7% | $586.4M +1.4% | $578.4M -0.4% | $580.9M | — |
| Total Debt | $113.0M -11.7% | $128.0M -22.9% | $166.0M -5.1% | $175.0M | — | — |
| Operating Cash Flow | $37.0M -34.3% | $56.4M +127.5% | $24.8M -0.7% | $25.0M -31.8% | $36.6M | — |
| Free Cash Flow | $25.8M -42.0% | $44.5M +213.2% | $14.2M -3.6% | $14.7M -36.0% | $23.0M | — |
Get alerted when CLB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Core Laboratories Inc. /DE/ including:
Top Institutional Holders of CLB
ARIEL INVESTMENTS, LLC
$164.0M14,074,945 shBlackRock, Inc.
$86.9M7,460,118 shDISCIPLINED GROWTH INVESTORS INC /MN
$35.4M3,042,177 shEARNEST PARTNERS LLC
$34.3M2,941,004 shSTATE STREET CORP
$25.4M2,176,480 shCWA Asset Management Group, LLC
$20.4M1,755,085 shVANGUARD CAPITAL MANAGEMENT LLC
$18.5M1,590,521 shDIMENSIONAL FUND ADVISORS LP
$18.0M1,548,203 shSCHRODER INVESTMENT MANAGEMENT GROUP
$16.9M1,543,638 shVANGUARD PORTFOLIO MANAGEMENT LLC
$14.9M1,275,421 sh
| Fund | Value | Shares |
|---|---|---|
| ARIEL INVESTMENTS, LLC | $164.0M | 14,074,945 |
| BlackRock, Inc. | $86.9M | 7,460,118 |
| DISCIPLINED GROWTH INVESTORS INC /MN | $35.4M | 3,042,177 |
| EARNEST PARTNERS LLC | $34.3M | 2,941,004 |
| STATE STREET CORP | $25.4M | 2,176,480 |
| CWA Asset Management Group, LLC | $20.4M | 1,755,085 |
| VANGUARD CAPITAL MANAGEMENT LLC | $18.5M | 1,590,521 |
| DIMENSIONAL FUND ADVISORS LP | $18.0M | 1,548,203 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $16.9M | 1,543,638 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $14.9M | 1,275,421 |
Companies Similar to CLB
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
EXPRO GROUP HOLDINGS N.V.
Borr Drilling Ltd
PATTERSON UTI ENERGY INC
NOV Inc.
VALVOLINE INC
HELIX ENERGY SOLUTIONS GROUP INC
Noble Corp plc
Drilling Tools International Corp
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Energy Companies
View all Energy →Put CLB on your watchlist
Track score changes the day Core Laboratories Inc. /DE/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CLB a good stock to buy?
13F Pro's AI-powered analysis of Core Laboratories Inc. /DE/ (CLB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Energy sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CLB are available on the CLB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CLB is classified as a small company.
Which hedge funds own CLB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CLB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Core Laboratories Inc. /DE/'s investment landscape.